272 related articles for article (PubMed ID: 34285233)
1. MARCH8 inhibits influenza A virus infection by targeting viral M2 protein for ubiquitination-dependent degradation in lysosomes.
Liu X; Xu F; Ren L; Zhao F; Huang Y; Wei L; Wang Y; Wang C; Fan Z; Mei S; Song J; Zhao Z; Cen S; Liang C; Wang J; Guo F
Nat Commun; 2021 Jul; 12(1):4427. PubMed ID: 34285233
[TBL] [Abstract][Full Text] [Related]
2. MARCH8 Restricts Influenza A Virus Infectivity but Does Not Downregulate Viral Glycoprotein Expression at the Surface of Infected Cells.
Villalón-Letelier F; Brooks AG; Londrigan SL; Reading PC
mBio; 2021 Oct; 12(5):e0148421. PubMed ID: 34517760
[TBL] [Abstract][Full Text] [Related]
3. Casein Kinase 1α Mediates the Degradation of Receptors for Type I and Type II Interferons Caused by Hemagglutinin of Influenza A Virus.
Xia C; Wolf JJ; Vijayan M; Studstill CJ; Ma W; Hahm B
J Virol; 2018 Apr; 92(7):. PubMed ID: 29343571
[TBL] [Abstract][Full Text] [Related]
4. BST-2 restricts IAV release and is countered by the viral M2 protein.
Hu S; Yin L; Mei S; Li J; Xu F; Sun H; Liu X; Cen S; Liang C; Li A; Guo F
Biochem J; 2017 Feb; 474(5):715-730. PubMed ID: 28087685
[TBL] [Abstract][Full Text] [Related]
5. Grail attenuates influenza A virus infection and pathogenesis by inhibiting viral nucleoprotein.
Lin HT; Chen CC; Liu PY; Wu HL; Wu TH; Huang CH; Chen YC
Sci Rep; 2018 Nov; 8(1):17242. PubMed ID: 30467324
[TBL] [Abstract][Full Text] [Related]
6. TRIM41-Mediated Ubiquitination of Nucleoprotein Limits Influenza A Virus Infection.
Patil G; Zhao M; Song K; Hao W; Bouchereau D; Wang L; Li S
J Virol; 2018 Aug; 92(16):. PubMed ID: 29899090
[TBL] [Abstract][Full Text] [Related]
7. Mechanism of Viral Glycoprotein Targeting by Membrane-Associated RING-CH Proteins.
Lun CM; Waheed AA; Majadly A; Powell N; Freed EO
mBio; 2021 Mar; 12(2):. PubMed ID: 33727347
[TBL] [Abstract][Full Text] [Related]
8. Mutations Conferring Increased Sensitivity to Tripartite Motif 22 Restriction Accumulated Progressively in the Nucleoprotein of Seasonal Influenza A (H1N1) Viruses between 1918 and 2009.
Pagani I; Di Pietro A; Oteiza A; Ghitti M; Mechti N; Naffakh N; Vicenzi E
mSphere; 2018 Apr; 3(2):. PubMed ID: 29624498
[TBL] [Abstract][Full Text] [Related]
9. PSMD12-Mediated M1 Ubiquitination of Influenza A Virus at K102 Regulates Viral Replication.
Hui X; Cao L; Xu T; Zhao L; Huang K; Zou Z; Ren P; Mao H; Yang Y; Gao S; Sun X; Lin X; Jin M
J Virol; 2022 Aug; 96(15):e0078622. PubMed ID: 35861516
[TBL] [Abstract][Full Text] [Related]
10. PARP1 Enhances Influenza A Virus Propagation by Facilitating Degradation of Host Type I Interferon Receptor.
Xia C; Wolf JJ; Sun C; Xu M; Studstill CJ; Chen J; Ngo H; Zhu H; Hahm B
J Virol; 2020 Mar; 94(7):. PubMed ID: 31915279
[TBL] [Abstract][Full Text] [Related]
11. Host Cellular Protein TRAPPC6AΔ Interacts with Influenza A Virus M2 Protein and Regulates Viral Propagation by Modulating M2 Trafficking.
Zhu P; Liang L; Shao X; Luo W; Jiang S; Zhao Q; Sun N; Zhao Y; Li J; Wang J; Zhou Y; Zhang J; Wang G; Jiang L; Chen H; Li C
J Virol; 2017 Jan; 91(1):. PubMed ID: 27795429
[TBL] [Abstract][Full Text] [Related]
12. MARCH8 Targets Cytoplasmic Lysine Residues of Various Viral Envelope Glycoproteins.
Zhang Y; Ozono S; Tada T; Tobiume M; Kameoka M; Kishigami S; Fujita H; Tokunaga K
Microbiol Spectr; 2022 Feb; 10(1):e0061821. PubMed ID: 35019698
[TBL] [Abstract][Full Text] [Related]
13. Potential Role of Nonneutralizing IgA Antibodies in Cross-Protective Immunity against Influenza A Viruses of Multiple Hemagglutinin Subtypes.
Okuya K; Yoshida R; Manzoor R; Saito S; Suzuki T; Sasaki M; Saito T; Kida Y; Mori-Kajihara A; Kondoh T; Sato M; Kajihara M; Miyamoto H; Ichii O; Higashi H; Takada A
J Virol; 2020 Jun; 94(12):. PubMed ID: 32269119
[TBL] [Abstract][Full Text] [Related]
14. MARCH8 Inhibits Ebola Virus Glycoprotein, Human Immunodeficiency Virus Type 1 Envelope Glycoprotein, and Avian Influenza Virus H5N1 Hemagglutinin Maturation.
Yu C; Li S; Zhang X; Khan I; Ahmad I; Zhou Y; Li S; Shi J; Wang Y; Zheng YH
mBio; 2020 Sep; 11(5):. PubMed ID: 32934085
[TBL] [Abstract][Full Text] [Related]
15. Ubiquitination of the Cytoplasmic Domain of Influenza A Virus M2 Protein Is Crucial for Production of Infectious Virus Particles.
Su WC; Yu WY; Huang SH; Lai MMC
J Virol; 2018 Feb; 92(4):. PubMed ID: 29167343
[TBL] [Abstract][Full Text] [Related]
16. H5N1 Influenza A Virus PB1-F2 Relieves HAX-1-Mediated Restriction of Avian Virus Polymerase PA in Human Lung Cells.
Mazel-Sanchez B; Boal-Carvalho I; Silva F; Dijkman R; Schmolke M
J Virol; 2018 Jun; 92(11):. PubMed ID: 29563290
[TBL] [Abstract][Full Text] [Related]
17. Viral Determinants in H5N1 Influenza A Virus Enable Productive Infection of HeLa Cells.
Rodriguez-Frandsen A; Martin-Sancho L; Gounder AP; Chang MW; Liu WC; De Jesus PD; von Recum-Knepper J; Dutra MS; Huffmaster NJ; Chavarria M; Mena I; Riva L; Nguyen CB; Dobariya S; Herbert KM; Benner C; Albrecht RA; García-Sastre A; Chanda SK
J Virol; 2020 Jan; 94(4):. PubMed ID: 31776276
[TBL] [Abstract][Full Text] [Related]
18. Influenza A Virus M2 Protein Apical Targeting Is Required for Efficient Virus Replication.
Wohlgemuth N; Lane AP; Pekosz A
J Virol; 2018 Nov; 92(22):. PubMed ID: 30158290
[TBL] [Abstract][Full Text] [Related]
19. Live Visualization of Hemagglutinin Dynamics During Infection by Using a Novel Reporter Influenza A Virus.
Dos Anjos Borges LG; Pisanelli G; Khatun O; García-Sastre A; Tripathi S
Viruses; 2020 Jun; 12(6):. PubMed ID: 32604762
[TBL] [Abstract][Full Text] [Related]
20. A Novel Mechanism Underlying Antiviral Activity of an Influenza Virus M2-Specific Antibody.
Manzoor R; Eguchi N; Yoshida R; Ozaki H; Kondoh T; Okuya K; Miyamoto H; Takada A
J Virol; 2020 Dec; 95(1):. PubMed ID: 33055251
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
